Human Genome Sciences is developing a drug, Albuferon, a combination of the human protein albumin and interferon.

FORBES: Magazine Article

Human Genome Sciences (nasdaq: HGSI - news - people ) is developing a drug, Albuferon, a combination of the human protein albumin and interferon.

FORBES: Saving Your Liver

McDonald suggests one likely target: Albuferon, an interferon drug for hepatitis C now in phase 2 trials that belongs to Human Genome Sciences.

FORBES

McDonald suggests one likely target: Albuferon, an interferon drug for hepatitis C now in phase 2 trials that belongs to Human Genome Sciences (nasdaq: HGSI - news - people ).

FORBES: Gilead's Half-Empty Pipeline

Anadys Pharmaceuticals is in early-stage human tests with drugs that stimulate the so-called TLR-7 receptor on immune cells to produce interferon just where it is needed.

FORBES: Magazine Article